Plaquenil

Hydroxychloroquine sulphate
200mg ( Brand) Sanofi
100TabletsRheumatoid arthritis74 €Buy Now

Rheumatic disorders

Hydroxychloroquine (HCQ), sold under the brand name Plaquenil among others, is a medication used for the prevention and treatment of certain types of malaria.[1] Specifically it is used for chloroquine-sensitive malaria.[2] Other uses include treatment of rheumatoid arthritis, lupus, and porphyria cutanea tarda.[1] It is taken by mouth.[1]

Common side effects include vomiting, headache, changes in vision and muscle weakness.[1] Severe side effects may include allergic reactions.[1] It does not appear to be safe during pregnancy.[3] Hydroxychloroquine is in the antimalarial and 4-aminoquinoline families of medication.[1]

Hydroxychloroquine was approved for medical use in the United States in 1955.[1] It is on the World Health Organization’s List of Essential Medicines, the safest and most effective medicines needed in a health system.[4] The wholesale cost in the developing world is about $4.65 per month as of 2015 when used for rheumatoid arthritis or lupus.[5] In the United States the wholesale cost of a month of treatment is about US$25 as of 2019.[6] In the United Kingdom this dose costs the NHS about £5.15.[7] In 2016 it was the 135th most prescribed medication in the United States with more than 4 million prescriptions

Hydroxychloroquine treats malaria, systemic lupus erythematosus, rheumatic disorders like rheumatoid arthritis, porphyria cutanea tarda, and Q fever.[1]

In 2014, its efficacy to treat Sjögren syndrome was questioned in a double-blind study involving 120 patients over a 48-week period.[9]

Hydroxychloroquine is widely used in the treatment of post-Lyme arthritis. It may have both an anti-spirochaete activity and an anti-inflammatory activity, similar to the treatment of rheumatoid arthritis